Mouse Anti-Human PSA Monoclonal Antibody (EX048)

Prostate-specific antigen (PSA) cannot distinguish between benign prostatic hyperplasia (BPH) and prostate cancer (PCa), resulting in a large number of unnecessary biopsies and missed cancer diagnoses. Nanovesicles called exosomes can be directly detected in patient plasma, and plasma exosomes expressing CD81 and PSA in PCa are significantly higher, achieving 100% specificity and sensitivity in distinguishing PCa patients from healthy individuals. Sensitivity.